A weight-loss research peptide. Live vendor vial prices, sorted lowest first.
For research use only. Not for human consumption. No health, dosing, or usage claims are made.
Cagrilintide is a long-acting synthetic analog of the hormone amylin, being developed by a pharmaceutical company as an investigational drug. It is not FDA-approved and any material sold as a research chemical is not an approved finished drug product.
CAS conflict: PubChem lists cagrilintide under CAS 1415456-99-3, which differs from the on-file 1949951-63-6 (likely a free-base vs salt/registry variant); identity as the amylin analog is confirmed but the CAS should be reconciled.
Regulatory status: As of 2026, cagrilintide is not FDA-approved; it is an investigational drug in clinical development and is not listed on the FDA 503A Category 2 bulk-substances list.
Typical vendor vial prices, Jul 2026. Exact prices load with verified listings.
| Vendor | Vial price | |
|---|---|---|
Simple Peptide | $0.05Best | View vendor › |
Precision Research Peptides | $0.13 | View vendor › |
Prime Lab Peptides | $0.16 | View vendor › |
Koi Peptides | $0.18 | View vendor › |
Protide Health | $0.20 | View vendor › |
BioInfinity Lab | $0.22 | View vendor › |
Kaia Peptides | $0.33 | View vendor › |
BioLongevity Labs | $0.50 | View vendor › |
Mile High Compounds | $1 | View vendor › |
PSPeptides | $3.60 | View vendor › |
Skye Peptides | $8.80 | View vendor › |
Studied in clinical and laboratory research of amylin signaling and metabolism; these remain areas of investigational study, not proven effects.
Planning a reconstitution? Use the calculator — it is math for handling a vial, not dosing.
Sources & further reading: PubChem CID 171397054 (NCBI)
How we source this ›